resourceId,resourceName,resourceType,observationText,observationType,observationPhase,observationTime,observationTimeUnits,doi
3978a8ca-aad8-49f5-a513-70b5acd0f92e,c.1185+1G > A NF1-mutant hiPSCs,['Cell Line'],"The c.1185+1G > A NF1-mutant hiPSCs exhibited increased RAS activity and RAS-regulated cell proliferation similar to patient-derived NPCs and organoids with the same mutation, as well as mouse models with analogous Nf1 mutations.","['Molecular function', 'Cellular phenotype']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3978a8ca-aad8-49f5-a513-70b5acd0f92e,c.1185+1G > A NF1-mutant hiPSCs,['Cell Line'],"The c.1185+1G > A NF1-mutant hiPSC line was one of the lines that successfully generated cerebral organoids exhibiting increased NPC proliferation, increased apoptosis, but similar numbers of immature neurons compared to controls.","['Developmental phenotype', 'Cellular phenotype']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3978a8ca-aad8-49f5-a513-70b5acd0f92e,c.1185+1G > A NF1-mutant hiPSCs,['Cell Line'],"The c.1185+1G > A NF1-mutant hiPSC line retained expression of the remaining wild-type NF1 allele, as confirmed by DNA and RNA sequencing.","['Genetics', 'Molecular characterization']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3978a8ca-aad8-49f5-a513-70b5acd0f92e,c.1185+1G > A NF1-mutant hiPSCs,['Cell Line'],The c.1185+1G > A NF1-mutant hiPSC line was generated using CRISPR/Cas9 technology to engineer the heterozygous mutation into a control human iPSC line.,"['Genetics', 'Resource development']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
3978a8ca-aad8-49f5-a513-70b5acd0f92e,c.1185+1G > A NF1-mutant hiPSCs,['Cell Line'],The c.1185+1G > A NF1-mutant hiPSC line was one of multiple isogenic NF1-mutant hiPSC lines generated to model different patient mutations in the NF1 gene.,"['Resource development', 'Disease modeling']",,,,https://doi.org/10.1016/j.stemcr.2020.03.007
